Abstract
A growing body of evidence has emerged in support of a pro-inflammatory role for adenosine in the pathogenic mechanisms of chronic inflammatory disorders of the airways such as asthma and COPD. The demonstration that adenosine enhances mast cell allergen-dependent activation, the notion that elevated levels of adenosine are present in chronically inflamed airways, and the results from exposure studies of nebulised adenosine showing dose-dependent bronchoconstriction in subjects with asthma and COPD, emphasise the importance of adenosine in the initiation, persistence and progression in these common inflammatory disorders of the airways. Adenosine exerts its manifold biological activities by interacting with at least four adenosine receptor subtypes. Selective activation or blockade of these sites is being exploited by the pharmaceutical industry in an attempt to generate novel therapies for asthma and COPD. This review article intends to address the potential role of adenosine in asthma and to put forward the idea that drugs that have been developed to selectively activate or downregulate adenosine receptor subtypes may constitute a considerable advance in the management of chronic airway inflammation.
Keywords: adenosine, adenosine receptors, inflammation, asthma, COPD
Current Drug Targets
Title: Adenosine Receptors As Promising Therapeutic Targets for Drug Development in Chronic Airway Inflammation
Volume: 7 Issue: 6
Author(s): Riccardo Polosa and Stephen T. Holgate
Affiliation:
Keywords: adenosine, adenosine receptors, inflammation, asthma, COPD
Abstract: A growing body of evidence has emerged in support of a pro-inflammatory role for adenosine in the pathogenic mechanisms of chronic inflammatory disorders of the airways such as asthma and COPD. The demonstration that adenosine enhances mast cell allergen-dependent activation, the notion that elevated levels of adenosine are present in chronically inflamed airways, and the results from exposure studies of nebulised adenosine showing dose-dependent bronchoconstriction in subjects with asthma and COPD, emphasise the importance of adenosine in the initiation, persistence and progression in these common inflammatory disorders of the airways. Adenosine exerts its manifold biological activities by interacting with at least four adenosine receptor subtypes. Selective activation or blockade of these sites is being exploited by the pharmaceutical industry in an attempt to generate novel therapies for asthma and COPD. This review article intends to address the potential role of adenosine in asthma and to put forward the idea that drugs that have been developed to selectively activate or downregulate adenosine receptor subtypes may constitute a considerable advance in the management of chronic airway inflammation.
Export Options
About this article
Cite this article as:
Polosa Riccardo and Holgate T. Stephen, Adenosine Receptors As Promising Therapeutic Targets for Drug Development in Chronic Airway Inflammation, Current Drug Targets 2006; 7 (6) . https://dx.doi.org/10.2174/138945006777435236
DOI https://dx.doi.org/10.2174/138945006777435236 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Advances in Exploring the Role of Micrornas in Inflammatory Bowel Disease
MicroRNA Immunosuppression-lipid Metabolism Interplay and Medicinal Plants in Atherosclerosis: A Review
Current Pharmaceutical Design Transbronchial Needle Aspiration (TBNA): Past Present and Future
Current Respiratory Medicine Reviews Voltage-Gated Sodium Channel Blockers as Immunomodulators
Recent Patents on CNS Drug Discovery (Discontinued) Vitamin D/VDR, Probiotics, and Gastrointestinal Diseases
Current Medicinal Chemistry Meet the Editorial Board Member
Recent Patents on Inflammation & Allergy Drug Discovery Clinical Evaluation of Exertional Dyspnea in Adult Pectus Excavatum Patients
Current Respiratory Medicine Reviews Quorum-Sensing Inhibitors and Biofilms
Anti-Infective Agents in Medicinal Chemistry Adverse Drug Reactions in the Oral Cavity
Current Pharmaceutical Design Control of Eosinophil Toxicity in the Lung
Current Drug Targets - Inflammation & Allergy Drug Repositioning: A Smart Approach for Combating SARS-CoV-2
Anti-Infective Agents Asthma and High Altitude: Is It Safe to Be and Work?
Current Respiratory Medicine Reviews Potentially Inappropriate Medication Use in Older People: A Crosssectional Study Using Beers Criteria
Current Drug Safety Platelet Resistance to the Anti-Aggregating Agents in the Insulin Resistant States
Current Diabetes Reviews Contemporary Methods for Patients to Report the Severity of Dyspnea
Current Respiratory Medicine Reviews Sphingolipids in Cell Signaling: Their Function as Receptor Ligands, Second Messengers, and Raft Constituents
Current Immunology Reviews (Discontinued) Lymphocyte Subsets in Patients with β-Thalassemia Major
Current Immunology Reviews (Discontinued) Platelet-Activating Factor (PAF): A Review of its Role in Asthma and Clinical Efficacy of PAF Antagonists in the Disease Therapy
Recent Patents on Inflammation & Allergy Drug Discovery Naturally Occurring NF-κB Inhibitors
Mini-Reviews in Medicinal Chemistry Structure-Function Relationships and Clinical Applications of L-Asparaginases
Current Medicinal Chemistry